Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dmitri Simberg

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
Nature Nanotechnology|January 16, 2019
Immunoglobulin deposition on biomolecule corona determines complement opsonization efficiency of preclinical and clinical nanoparticlesVivian P Vu, Geoffrey B Gifford, Fangfang Chen, et al.
Molecular Pharmaceutics|May 16, 2019
Evaluation of Targeting Efficiency of Joints with Anticollagen II AntibodiesLaren A Lofchy, Vivian P Vu, Nirmal K Banda, et al.
Nature Nanotechnology|October 5, 2023
Inhibition of acute complement responses towards bolus-injected nanoparticles using targeted short-circulating regulatory proteinsYue Li, Sarah Jacques, Hanmant Gaikwad, et al.
Nature Nanotechnology|January 24, 2019
Publisher Correction: Immunoglobulin deposition on biomolecule corona determines complement opsonization efficiency of preclinical and clinical nanoparticlesVivian P Vu, Geoffrey B Gifford, Fangfang Chen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 12, 2019
Complement therapeutics meets nanomedicine: overcoming human complement activation and leukocyte uptake of nanomedicines with soluble domains of CD55Geoffrey Gifford, Vivian P Vu, Nirmal K Banda, et al.
Nature Nanotechnology|December 20, 2016
Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivoFangfang Chen, Guankui Wang, James I Griffin, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 20, 2020
Delivery of a model lipophilic membrane cargo to bone marrow via cell-derived microparticlesChunyan Yang, Fangfang Chen, Ping Ren, et al.
Cancer Research|December 2, 2020
Preclinical Applications of Multi-Platform Imaging in Animal Models of CancerNatalie J Serkova, Kristine Glunde, Chad R Haney, et al.
Immune Network|May 10, 2024
Decay-Accelerating Factor Differentially Associates With Complement-Mediated Damage in Synovium After Meniscus Tear as Compared to Anterior Cruciate Ligament InjuryV Michael Holers, Rachel M Frank, Michael Zuscik, et al.
Frontiers in Immunology|November 12, 2020
C2 IgM Natural Antibody Enhances Inflammation and Its Use in the Recombinant Single Chain Antibody-Fused Complement Inhibitor C2-Crry to Target Therapeutics to Joints Attenuates Arthritis in MiceNirmal K Banda, Stephen Tomlinson, Robert I Scheinman, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Nature Nanotechnology|January 16, 2019
Immunoglobulin deposition on biomolecule corona determines complement opsonization efficiency of preclinical and clinical nanoparticlesVivian P Vu, Geoffrey B Gifford, Fangfang Chen, et al.
Molecular Pharmaceutics|May 16, 2019
Evaluation of Targeting Efficiency of Joints with Anticollagen II AntibodiesLaren A Lofchy, Vivian P Vu, Nirmal K Banda, et al.
Nature Nanotechnology|October 5, 2023
Inhibition of acute complement responses towards bolus-injected nanoparticles using targeted short-circulating regulatory proteinsYue Li, Sarah Jacques, Hanmant Gaikwad, et al.
Nature Nanotechnology|January 24, 2019
Publisher Correction: Immunoglobulin deposition on biomolecule corona determines complement opsonization efficiency of preclinical and clinical nanoparticlesVivian P Vu, Geoffrey B Gifford, Fangfang Chen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 12, 2019
Complement therapeutics meets nanomedicine: overcoming human complement activation and leukocyte uptake of nanomedicines with soluble domains of CD55Geoffrey Gifford, Vivian P Vu, Nirmal K Banda, et al.
Nature Nanotechnology|December 20, 2016
Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivoFangfang Chen, Guankui Wang, James I Griffin, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 20, 2020
Delivery of a model lipophilic membrane cargo to bone marrow via cell-derived microparticlesChunyan Yang, Fangfang Chen, Ping Ren, et al.
Cancer Research|December 2, 2020
Preclinical Applications of Multi-Platform Imaging in Animal Models of CancerNatalie J Serkova, Kristine Glunde, Chad R Haney, et al.
Immune Network|May 10, 2024
Decay-Accelerating Factor Differentially Associates With Complement-Mediated Damage in Synovium After Meniscus Tear as Compared to Anterior Cruciate Ligament InjuryV Michael Holers, Rachel M Frank, Michael Zuscik, et al.
Frontiers in Immunology|November 12, 2020
C2 IgM Natural Antibody Enhances Inflammation and Its Use in the Recombinant Single Chain Antibody-Fused Complement Inhibitor C2-Crry to Target Therapeutics to Joints Attenuates Arthritis in MiceNirmal K Banda, Stephen Tomlinson, Robert I Scheinman, et al.
Pageof 10